Antimicrobial resistance (AMR), the resistance of microbes towards medicine, has been stated to be one of the mort significant challenges to the heath care rector in the 21st century and one of the biggest global heath problems today. It is a complex and multifaceted problem which requires many concurrent solutions – one of them is the development of new antibiotics, alternatives to antibiotics and appropriate diagnostics. This report has focused on this limited pipeline, for which innovation is required.